P3 Health PartnersPIII -9.50%47 EPS without NRI is $-39.98 as of Mar. 2026. GuruFocus rates PIII with a GF Score™ of 47/100 and a GF Value™ of $9.22 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 511 Healthcare Providers & Services companies, P3 Health Partners ranks worse than 195694.52% on this metric.
P3 Health Partners's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was $0.30.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-39.98.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for P3 Health Partners's EPS without NRI or its related term are showing as below:
During the past 8 years, P3 Health Partners's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -11.10% per year. The lowest was -11.10% per year. And the median was -11.10% per year.
PIII's 3-Year EPS without NRI Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.5 * Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
P3 Health Partners's EPS (Basic) for the
three
months ended in Mar. 2026 was $0.37.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-38.55.
P3 Health Partners (NAS:PIII) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
P3 Health Partners EPS without NRI Related Terms
P3 Health Partners EPS without NRI Historical Data
* Premium members only.
The historical data trend for P3 Health Partners's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PIII vs EHSI, CDIX, DCGO: EPS without NRI Comparison
For the Medical Care Facilities subindustry, P3 Health Partners's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
P3 Health Partners PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where P3 Health Partners's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-39.98
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
P3 Health Partners (PIII) has a EPS without NRI of $-39.98 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on P3 Health Partners and its competitors. According to the industry distribution chart, P3 Health Partners ranks #999999 out of 511 companies in the Healthcare Providers & Services industry.
Is P3 Health Partners' EPS without NRI too high?
P3 Health Partners' current EPS without NRI is $-39.98. Based on the distribution chart, P3 Health Partners ranks #999999 out of 511 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, P3 Health Partners has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' EPS without NRI compare to EHSI and CDIX?
According to the Healthcare Providers & Services industry distribution chart, P3 Health Partners ranks #999999 out of 511 companies for EPS without NRI. This places P3 Health Partners in the lower half of its industry. The industry median EPS without NRI is 11.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.50, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on P3 Health Partners and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. P3 Health Partners's current EPS without NRI is $-39.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
Based on GuruFocus' analysis, P3 Health Partners (PIII) is currently considered Modestly Overvalued. The stock's GF Value™ is $9.22, compared to a current price of $10.28 — trading 11.5% above its estimated fair value. The current EPS without NRI is $-39.98. P3 Health Partners' overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For P3 Health Partners (PIII), the current EPS without NRI is $-39.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is P3 Health Partners (PIII) Overvalued in 2026?
Based on GuruFocus' analysis, P3 Health Partners stock appears to be overvalued.
The current stock price of $10.28 is trading 11.5% above its estimated GF Value™ of $9.22.
GuruFocus considers P3 Health Partners to be Modestly Overvalued.
Key valuation signals for PIII:
EPS without NRI: $-39.98
GF Value™: $9.22 vs. price of $10.28 (11.5% above fair value)
No single metric tells the full story. See the PIII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
47GF Score
Get the complete analysis for PIII
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PIII has been successfully added to your 
